Showing results (51-60 of 5,585) with videos related to

Sort By:
Pageof 559
Leukemia & Lymphoma|December 28, 1999
Clinical significance of the translocation (11;14)(q13;q32) in multiple myelomaR Fonseca, J D Hoyer, P Aguayo, et al.
Bone Marrow Transplantation|December 2, 2000
Effect of complete response on outcome following autologous stem cell transplantation for myelomaS V Rajkumar, R Fonseca, A Dispenzieri, et al.
Leukemia & Lymphoma|June 1, 2000
A prospective study of CD38/45 flow cytometry and immunofluorescence microscopy to detect blood plasma cells in patients with plasma cell proliferative disordersT E Witzig, C Meyers, T Therneau, et al.
Leukemia & Lymphoma|August 26, 1998
Measurement of the cell proliferation rate of bone marrow erythroid precursors by flow cytometry: initial applications to multiple myelomaM Timm, T K Kimlinger, C Hanson, et al.
Blood Cancer Journal|October 27, 2015
Characteristics of exceptional responders to lenalidomide-based therapy in multiple myelomaT Vu, W Gonsalves, S Kumar, et al.
Cancer|May 1, 1995
Primary renal non-Hodgkin's lymphoma. An unusual extranodal siteS H Okuno, J D Hoyer, K Ristow, et al.
Leukemia|January 19, 2007
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapyA K Stewart, P L Bergsagel, P R Greipp, et al.
Medical Oncology (Northwood, London, England)|October 19, 1999
Prevention of recurrence and prolonged survival in primary central nervous system lymphoma (PCNSL) patients treated with adjuvant high-dose methylprednisoloneB P O'Neill, T M Habermann, T E Witzig, et al.
American Journal of Clinical Pathology|March 1, 1994
Measurement of the intensity of cell surface antigen expression in B-cell chronic lymphocytic leukemiaT E Witzig, C Y Li, A Tefferi, et al.
Leukemia & Lymphoma|June 1, 1994
Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analoguesT E Witzig, J J Weitz, J H Lundberg, et al.
Pageof 559